In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
A recent study published in JAMA Network Open evaluated the cost-effectiveness of monoclonal antibodies (mAbs) as pre-exposure prophylaxis (PrEP) for coronavirus disease 2019 (COVID-19). Study: Health ...
A new survey finds that men who would be potential users of HIV pre-exposure prophylaxis (PrEP) medication prefer long-acting injections over pills, but rank side effects and costs as the most ...
Among individuals using HIV pre-exposure prophylaxis (HIV PrEP), doxycycline post-exposure prophylaxis (doxyPEP) was associated with a substantial decline in chlamydia and syphilis incidence.
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
Postexposure HIV prophylaxis has been recommended for men who have sex with men, but the window to start treatment is short (72 hours) and evidence for its efficacy is limited. The recent Pre-exposure ...
LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.
HIV pre-exposure prophylaxis (PrEP) is an effective and safe intervention for individuals with behaviors that are considered high risk for acquiring HIV infection. Despite the success of this ...
In a separate study, Jean-Michel Molina, PhD, of the University of Paris Diderot, Paris, France, and colleagues examined the efficacy of “on demand” PrEP high in risk MSM. “Daily PrEP with oral ...
In their research article published in Eurosurveillance, von Schreeb et al. challenge existing assumptions regarding the relationship between the use of HIV pre-exposure prophylaxis (PrEP) and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results